| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Molecular Immunology and Pathology [K. I., E. O., Y. O.], Surgery [H. N.], and Virology and Oncology [H. S., M. S.], Cancer Research Institute, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa 920; Fuji Chemical Industries Ltd., Takaoka, Toyama 933 [E. O., T. A.]; and Department of Chemistry, Fukui Medical School, Fukui 910-11 [Y. F.], Japan
The processing mechanism and gelatinolytic activity of the membranetype matrix metalloproteinase 1 (MT-MMP-1) were examined by expressing in COS-1 cells a deletion mutant of MT-MMP-1 lacking the transmembrane domain (
MT1) and its site-directed mutant with a furinresistant sequence in the propeptide domain (mutant
MT1).
MT1, but not mutant
MT1, was processed to an active form and exhibited gelatinolytic activity as seen using gelatin zymography.
MT1 isolated in a complex form with tissue inhibitor of metalloproteinases 2 (TIMP-2) from the stable transfectants demonstrated the NH2-terminal sequence of Ala113-IIe-Gln-Gly-Leu, indicating cleavage at one amino acid down-stream from the furin recognition sequence. The
MT1/TIMP-2 complex formed a ternary complex with proMMP-2 through the COOH termini of TIMP-2 and proMMP-2. A human breast carcinoma cell line (MDA-MB-231 cells) also secreted MT-MMP-1 into culture media, which was purified in a complex form with TIMP-2 and showed gelatinolytic activity as seen using zymography. These results demonstrate for the first time that MT-MMP-1 is a gelatinolytic enzyme and secreted from cells in a complex with TIMP-2, which can form a ternary complex of MT-MMP-1/TIMP-2/proMMP-2.
1 Supported by a Grant-in-Aid from the Ministry of Education, Science, and Culture of Japan (Y. O.).
2 Recipient of Research Fellowship from the Japan Society for the Promotion of Science for Young Scientists.
3 To whom requests for reprints should be addressed. Phone: 81-762-34-4507; Fax: 81-762-34-4508; E-mail: yasokada@kenroku.ipc.kanazawa-u.ac.jp.
Received 3/ 4/96. Accepted 4/30/96.
This article has been cited by other articles:
![]() |
H. Piccard, P. E. Van den Steen, and G. Opdenakker Hemopexin domains as multifunctional liganding modules in matrix metalloproteinases and other proteins J. Leukoc. Biol., April 1, 2007; 81(4): 870 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Verstappen and J.W. Von den Hoff Tissue Inhibitors of Metalloproteinases (TIMPs): Their Biological Functions and Involvement in Oral Disease. J. Dent. Res., December 1, 2006; 85(12): 1074 - 1084. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lee, C. M. Overall, C. A. McCulloch, and J. Sodek A Critical Role for the Membrane-type 1 Matrix Metalloproteinase in Collagen Phagocytosis Mol. Biol. Cell, November 1, 2006; 17(11): 4812 - 4826. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stefanidakis and E. Koivunen Cell-surface association between matrix metalloproteinases and integrins: role of the complexes in leukocyte migration and cancer progression Blood, September 1, 2006; 108(5): 1441 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. McLennan, X. Y. Wang, V. Moreno, D. K. Yue, and S. M. Twigg Connective Tissue Growth Factor Mediates High Glucose Effects on Matrix Degradation through Tissue Inhibitor of Matrix Metalloproteinase Type 1: Implications for Diabetic Nephropathy Endocrinology, December 1, 2004; 145(12): 5646 - 5655. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kohno, A. Ishizaka, M. Sawafuji, H. Koh, Y. Hirayama, E. Ikeda, T. Shiomi, A. Ohashi, Y. Okada, and K. Kobayashi Hyperoxia-induced emphysematous changes in subacute phase of endotoxin-induced lung injury in rats Am J Physiol Lung Cell Mol Physiol, July 1, 2004; 287(1): L184 - L190. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Uraguchi, M. Morikawa, M. Shirakawa, K. Sanada, and K. Imai Activation of WNT Family Expression and Signaling in Squamous Cell Carcinomas of the Oral Cavity J. Dent. Res., April 1, 2004; 83(4): 327 - 332. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Katayama, N. Bandoh, K. Kishibe, M. Takahara, T. Ogino, S. Nonaka, and Y. Harabuchi Expressions of Matrix Metalloproteinases in Early-Stage Oral Squamous Cell Carcinoma as Predictive Indicators for Tumor Metastases and Prognosis Clin. Cancer Res., January 15, 2004; 10(2): 634 - 640. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Cheng and D. H. Lovett Gelatinase A (MMP-2) Is Necessary and Sufficient for Renal Tubular Cell Epithelial-Mesenchymal Transformation Am. J. Pathol., June 1, 2003; 162(6): 1937 - 1949. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Manase, T. Endo, H. Henmi, Y. Kitajima, K. Yamazaki, A. Nishikawa, T. Mitaka, H. Sato, and R. Kudo The significance of membrane type 1 metalloproteinase in structural involution of human corpora lutea Mol. Hum. Reprod., August 1, 2002; 8(8): 742 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Toth, S. Hernandez-Barrantes, P. Osenkowski, M. M. Bernardo, D. C. Gervasi, Y. Shimura, O. Meroueh, L. P. Kotra, B. G. Galvez, A. G. Arroyo, et al. Complex Pattern of Membrane Type 1 Matrix Metalloproteinase Shedding. REGULATION BY AUTOCATALYTIC CELL SURFACE INACTIVATION OF ACTIVE ENZYME J. Biol. Chem., July 12, 2002; 277(29): 26340 - 26350. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhang, L. Yan, M. A. Moses, and P. C.W. Tsang Bovine Membrane-Type 1 Matrix Metalloproteinase: Molecular Cloning and Expression in the Corpus Luteum Biol Reprod, July 1, 2002; 67(1): 99 - 106. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Kridel, H. Sawai, B. I. Ratnikov, E. I. Chen, W. Li, A. Godzik, A. Y. Strongin, and J. W. Smith A Unique Substrate Binding Mode Discriminates Membrane Type-1 Matrix Metalloproteinase from Other Matrix Metalloproteinases J. Biol. Chem., June 21, 2002; 277(26): 23788 - 23793. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Gilles, M. Polette, C. Coraux, J.-M. Tournier, G. Meneguzzi, C. Munaut, L. Volders, P. Rousselle, P. Birembaut, and J.-M. Foidart Contribution of MT1-MMP and of human laminin-5 {gamma}2 chain degradation to mammary epithelial cell migration J. Cell Sci., March 10, 2002; 114(16): 2967 - 2976. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lehti, J. Lohi, M. M. Juntunen, D. Pei, and J. Keski-Oja Oligomerization through Hemopexin and Cytoplasmic Domains Regulates the Activity and Turnover of Membrane-type 1 Matrix Metalloproteinase J. Biol. Chem., March 1, 2002; 277(10): 8440 - 8448. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. Hotary, I. Yana, F. Sabeh, X.-Y. Li, K. Holmbeck, H. Birkedal-Hansen, E. D. Allen, N. Hiraoka, and S. J. Weiss Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP-dependent and -independent Processes J. Exp. Med., January 28, 2002; 195(3): 295 - 308. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Romanic, C. L. Burns-Kurtis, Z. Ao, A. J. Arleth, and E. H. Ohlstein Upregulated expression of human membrane type-5 matrix metalloproteinase in kidneys from diabetic patients Am J Physiol Renal Physiol, August 1, 2001; 281(2): F309 - F317. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hernandez-Barrantes, M. Toth, M. M. Bernardo, M. Yurkova, D. C. Gervasi, Y. Raz, Q. A. Sang, and R. Fridman Binding of Active (57 kDa) Membrane Type 1-Matrix Metalloproteinase (MT1-MMP) to Tissue Inhibitor of Metalloproteinase (TIMP)-2 Regulates MT1-MMP Processing and Pro-MMP-2 Activation J. Biol. Chem., April 14, 2000; 275(16): 12080 - 12089. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. LENZ, S. J. ELLIOT, and W. G. STETLER-STEVENSON Matrix Metalloproteinases in Renal Development and Disease J. Am. Soc. Nephrol., March 1, 2000; 11(3): 574 - 581. [Full Text] [PDF] |
||||
![]() |
Y. S. Kanwar, K. Ota, Q. Yang, J. Wada, N. Kashihara, Y. Tian, and E. I. Wallner Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis Am J Physiol Renal Physiol, December 1, 1999; 277(6): F934 - F947. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Barille, R. Bataille, M.-J. Rapp, J.-L. Harousseau, and M. Amiot Production of Metalloproteinase-7 (Matrilysin) by Human Myeloma Cells and Its Potential Involvement in Metalloproteinase-2 Activation J. Immunol., November 15, 1999; 163(10): 5723 - 5728. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Rajavashisth, X.-P. Xu, S. Jovinge, S. Meisel, X.-O. Xu, N.-N. Chai, M. C. Fishbein, S. Kaul, B. Cercek, B. Sharifi, et al. Membrane Type 1 Matrix Metalloproteinase Expression in Human Atherosclerotic Plaques : Evidence for Activation by Proinflammatory Mediators Circulation, June 22, 1999; 99(24): 3103 - 3109. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Michael, B. Babic, R. Khokha, M. Tsao, J. Ho, M. Pintilie, K. Leco, D. Chamberlain, and F. A. Shepherd Expression and Prognostic Significance of Metalloproteinases and Their Tissue Inhibitors in Patients With Small-Cell Lung Cancer J. Clin. Oncol., June 1, 1999; 17(6): 1802 - 1802. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Rajavashisth, J. K. Liao, Z. S. Galis, S. Tripathi, U. Laufs, J. Tripathi, N.-N. Chai, X.-P. Xu, S. Jovinge, P. K. Shah, et al. Inflammatory Cytokines and Oxidized Low Density Lipoproteins Increase Endothelial Cell Expression of Membrane Type 1-Matrix Metalloproteinase J. Biol. Chem., April 23, 1999; 274(17): 11924 - 11929. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pei Identification and Characterization of the Fifth Membrane-type Matrix Metalloproteinase MT5-MMP J. Biol. Chem., March 26, 1999; 274(13): 8925 - 8932. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakada, H. Nakamura, E. Ikeda, N. Fujimoto, J. Yamashita, H. Sato, M. Seiki, and Y. Okada Expression and Tissue Localization of Membrane-Type 1, 2, and 3 Matrix Metalloproteinases in Human Astrocytic Tumors Am. J. Pathol., February 1, 1999; 154(2): 417 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T.J. Belien, P. A. Paganetti, and M. E. Schwab Membrane-type 1 Matrix Metalloprotease (MT1-MMP) Enables Invasive Migration of Glioma Cells in Central Nervous System White Matter J. Cell Biol., January 25, 1999; 144(2): 373 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cao, M. Drews, H. M. Lee, C. Conner, W. F. Bahou, and S. Zucker The Propeptide Domain of Membrane Type 1 Matrix Metalloproteinase Is Required for Binding of Tissue Inhibitor of Metalloproteinases and for Activation of Pro-gelatinase A J. Biol. Chem., December 25, 1998; 273(52): 34745 - 34752. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Itoh, A. Ito, K. Iwata, K. Tanzawa, Y. Mori, and H. Nagase Plasma Membrane-bound Tissue Inhibitor of Metalloproteinases (TIMP)-2 Specifically Inhibits Matrix Metalloproteinase 2 (Gelatinase A) Activated on the Cell Surface J. Biol. Chem., September 18, 1998; 273(38): 24360 - 24367. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kinoshita, H. Sato, A. Okada, E. Ohuchi, K. Imai, Y. Okada, and M. Seiki TIMP-2 Promotes Activation of Progelatinase A by Membrane-type 1 Matrix Metalloproteinase Immobilized on Agarose Beads J. Biol. Chem., June 26, 1998; 273(26): 16098 - 16103. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Butler, M. J. Butler, S. J. Atkinson, H. Will, T. Tamura, S. S. van Westrum, T. Crabbe, J. Clements, M.-P. d'Ortho, and G. Murphy The TIMP2 Membrane Type 1 Metalloproteinase "Receptor" Regulates the Concentration and Efficient Activation of Progelatinase A. A KINETIC STUDY J. Biol. Chem., January 9, 1998; 273(2): 871 - 880. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zucker, M. Drews, C. Conner, H. D. Foda, Y. A. DeClerck, K. E. Langley, W. F. Bahou, A. J. P. Docherty, and J. Cao Tissue Inhibitor of Metalloproteinase-2 (TIMP-2) Binds to the Catalytic Domain of the Cell Surface Receptor, Membrane Type 1-Matrix Metalloproteinase 1 (MT1-MMP) J. Biol. Chem., January 9, 1998; 273(2): 1216 - 1222. [Abstract] [Full Text] [PDF] |
||||
![]() |
H Stanton, J Gavrilovic, S. Atkinson, M. d'Ortho, K. Yamada, L Zardi, and G Murphy The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form J. Cell Sci., January 9, 1998; 111(18): 2789 - 2798. [Abstract] [PDF] |
||||
![]() |
S. S. Apte, N. Fukai, D. R. Beier, and B. R. Olsen The Matrix Metalloproteinase-14 (MMP-14) Gene Is Structurally Distinct from Other MMP Genes and Is Co-expressed with the TIMP-2 Gene during Mouse Embryogenesis J. Biol. Chem., October 10, 1997; 272(41): 25511 - 25517. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Barille, C. Akhoundi, M. Collette, M.-P. Mellerin, M.-J. Rapp, J.-L. Harousseau, R. Bataille, and M. Amiot Metalloproteinases in Multiple Myeloma: Production of Matrix Metalloproteinase-9 (MMP-9), Activation of proMMP-2, and Induction of MMP-1 by Myeloma Cells Blood, August 15, 1997; 90(4): 1649 - 1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakahara, L. Howard, E. W. Thompson, H. Sato, M. Seiki, Y. Yeh, and W.-T. Chen Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion PNAS, July 22, 1997; 94(15): 7959 - 7964. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-Y. Lin, J.-K. Wang, J. Torri, L. Dou, Q. A. Sang, and R. B. Dickson Characterization of a Novel, Membrane-bound, 80-kDa Matrix-degrading Protease from Human Breast Cancer Cells. MONOCLONAL ANTIBODY PRODUCTION, ISOLATION, AND LOCALIZATION J. Biol. Chem., April 4, 1997; 272(14): 9147 - 9152. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ohuchi, K. Imai, Y. Fujii, H. Sato, M. Seiki, and Y. Okada Membrane Type 1Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules J. Biol. Chem., January 24, 1997; 272(4): 2446 - 2451. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Deryugina, M. Bourdon, G. Luo, R. Reisfeld, and A Strongin Matrix metalloproteinase-2 activation modulates glioma cell migration J. Cell Sci., January 10, 1997; 110(19): 2473 - 2482. [Abstract] [PDF] |
||||
![]() |
T Sato, M del Carmen Ovejero, P Hou, A. Heegaard, M Kumegawa, N. Foged, and J. Delaisse Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts J. Cell Sci., January 3, 1997; 110(5): 589 - 596. [Abstract] [PDF] |
||||
![]() |
J. Cao, A. Rehemtulla, W. Bahou, and S. Zucker Membrane Type Matrix Metalloproteinase 1Activates Pro-gelatinase A without Furin Cleavage of the N-terminal Domain J. Biol. Chem., November 22, 1996; 271(47): 30174 - 30180. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cao, M. Hymowitz, C. Conner, W. F. Bahou, and S. Zucker The Propeptide Domain of Membrane Type 1-Matrix Metalloproteinase Acts as an Intramolecular Chaperone when Expressed in trans with the Mature Sequence in COS-1 Cells J. Biol. Chem., September 15, 2000; 275(38): 29648 - 29653. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhuge and J. Xu Rac1 Mediates Type I Collagen-dependent MMP-2 Activation. ROLE IN CELL INVASION ACROSS COLLAGEN BARRIER J. Biol. Chem., May 4, 2001; 276(19): 16248 - 16256. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Lehti, H. Valtanen, S. Wickstrom, J. Lohi, and J. Keski-Oja Regulation of Membrane-type-1 Matrix Metalloproteinase Activity by Its Cytoplasmic Domain J. Biol. Chem., May 12, 2000; 275(20): 15006 - 15013. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |